You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

latent tuberculosis infection

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Latent Tuberculosis Infection in Health-care Workers and

Recruiting
  • Tuberculosis
  • +4 more
  • Prevalence of Latent Tuberculosis Infection
  • Roma, Italy
    UOSD Allergologia e Immunologia Clinica, Fondazione Policlinico
Mar 1, 2023

Tuberculosis, Latent Tuberculosis Infection Trial in Bijie, Linping, Qingzhen (QuantiFERON-TB Gold (QFT) test)

Recruiting
  • Tuberculosis
  • Latent Tuberculosis Infection
  • QuantiFERON-TB Gold (QFT) test
  • Bijie, Guizhou, China
  • +4 more
Sep 12, 2023

Methods in People Living With Retroviral Infection in Liberia

Active, not recruiting
  • Tuberculosis
  • HIV
    • Bethesda, Maryland
    • +4 more
    Jan 14, 2023

    Latent Tuberculosis Trial (CDC/NTCA guidelines only, LTBI ASSIST and CDC/NTCA guidelines only)

    Not yet recruiting
    • Latent Tuberculosis
    • CDC/NTCA guidelines only
    • LTBI ASSIST and CDC/NTCA guidelines only
    • (no location specified)
    Mar 7, 2023

    Latent Tuberculosis Infection Trial in Taipei (isoniazid and rifapentine)

    Recruiting
    • Latent Tuberculosis Infection
    • isoniazid and rifapentine
    • Taipei, Taiwan
      National Taiwan University Hospital
    Nov 22, 2022

    Latent Tuberculosis Infection Trial (Mycobacterium Vaccae for Injection)

    Not yet recruiting
    • Latent Tuberculosis Infection
    • Mycobacterium Vaccae for Injection
    • (no location specified)
    Dec 23, 2022

    Pulmonology Trial in Taipei (Rifamycin-containing regimen, Rifamycin-free regimen)

    Recruiting
    • Pulmonology
    • Rifamycin-containing regimen
    • Rifamycin-free regimen
    • Taipei, Taiwan
      National Taiwan University Hospital
    Oct 18, 2022

    Latent Tuberculosis Infection Trial (Recombinant Mycobacterium Tuberculosis Fusion Protein, Purified Protein Derivative of

    Not yet recruiting
    • Latent Tuberculosis Infection
    • Recombinant Mycobacterium Tuberculosis Fusion Protein
    • Purified Protein Derivative of Tuberculin
    • (no location specified)
    Jun 8, 2023

    Latent Tuberculosis Infection Trial (Recombinant Mycobacterium tuberculosis fusion protein for injection, TB-PPD was injected)

    Not yet recruiting
    • Latent Tuberculosis Infection
    • Recombinant Mycobacterium tuberculosis fusion protein for injection
    • TB-PPD was injected
    • (no location specified)
    Feb 16, 2023

    Latent Tuberculosis Trial in Baltimore (Usual Care, Video Directly Observed Therapy alone, Video Directly Observed Therapy plus

    Recruiting
    • Latent Tuberculosis
    • Usual Care
    • +2 more
    • Baltimore, Maryland
      Baltimore City Health Department
    Feb 8, 2022

    Latent Tuberculosis Infection Trial in Columbia (BST, TST, QFT)

    Active, not recruiting
    Has Results
    • Latent Tuberculosis Infection
    • Columbia, South Carolina
      Fort Jackson, SC
    Dec 16, 2021

    Tuberculosis, HIV Trial (Dolutegravir, 3HP)

    Not yet recruiting
    • Tuberculosis
    • HIV
    • (no location specified)
    Dec 9, 2022

    Healthy, Latent Tuberculosis Infection (LTBI) Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Tuberculin

    Recruiting
    • Healthy
    • Latent Tuberculosis Infection (LTBI)
    • Tuberculin Purified Protein Derivative
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jul 22, 2022

    Diagnosis of Tuberculosis Infection in HIV Co-infected Children

    Completed
    • Latent Tuberculosis Infection
    • +2 more
      • Tygerberg, Western Cape, South Africa
        Despond TuTu TB Centre, Stellenbosch University
      Jan 3, 2022

      Latent Tuberculosis, Persistent Infection, Mycobacterium Tuberculosis Trial in Malmö

      Recruiting
      • Latent Tuberculosis
      • +2 more
        • Malmö, Skåne, Sweden
          Skåne University Hospital
        Nov 10, 2022

        Latent Tuberculosis Trial in London (Community/Primary Care, Hospital/TB Clinic)

        Completed
        • Latent Tuberculosis
        • Community/Primary Care
        • Hospital/TB Clinic
        • London, United Kingdom
          Shrewsbury Road Health Centre
        Nov 24, 2021

        Tuberculosis Trial in Worcester (MTBVAC, BCG)

        Completed
        • Tuberculosis
        • MTBVAC
        • BCG
        • Worcester, South Africa
          SATVI: Worcester
        Sep 6, 2021

        HIV-infected Participants With Latent TB Infection in High TB Burden Country Trial in Thailand (Isoniazid/Rifapentine daily (4

        Recruiting
        • HIV-infected Participants With Latent TB Infection in High TB Burden Country
        • Isoniazid/Rifapentine daily (4 weeks) plus pyridoxine (vitamin B6)
        • Isoniazid/Rifapentine 12-weekly plus pyridoxine (vitamin B6)
        • Bangkok, Thailand
        • +15 more
        Mar 22, 2022

        Tuberculosis Infection Trial in Saint Petersburg (TB/Flu-05E vaccine, Placebo)

        Active, not recruiting
        • Tuberculosis Infection
        • TB/Flu-05E vaccine
        • Placebo
        • Saint Petersburg, Russian Federation
          Smorodintsev Research Institute of Influenza
        Jul 11, 2023

        Latent Tuberculosis Trial in Bangkok (TST vs PPD microneedle test)

        Recruiting
        • Latent Tuberculosis
        • TST vs PPD microneedle test
        • Bangkok, Thailand
          Faculty of Medicine, Chulalongkorn University
        Aug 23, 2021

        Latent Tuberculosis, Diabete Mellitus, Malnutrition Trial in Chennai

        Recruiting
        • Latent Tuberculosis
        • +3 more
          • Chennai, Tamilnadu, India
            National Institute for Research in Tuberculosis
          Jul 6, 2022

          Malnutrition, Diabetes Mellitus, and Helminth Infections on

          Active, not recruiting
          • Mycobacterium Tuberculosis
          • +4 more
            • Chennai, India
              National Institute for Research In Tuberculosis, International C
            Jul 28, 2022

            Latent Tuberculosis Trial in London (IGRA blood test used as a tool for opt-out screening for latent Tuberculsis infection)

            Active, not recruiting
            • Latent Tuberculosis
            • IGRA blood test used as a tool for opt-out screening for latent Tuberculsis infection
            • London, Essex, United Kingdom
            • +2 more
            Sep 21, 2021

            Compliance, Patient Trial in Aarhus, Esbjerg (Rifapentine, Isoniazid)

            Recruiting
            • Compliance, Patient
            • Aarhus, Denmark
            • +1 more
            Jul 26, 2021

            Tuberculosis Infection, HIV Trial in Zomba (CAD4TB, FujiLAM)

            Completed
            • Tuberculosis Infection
            • HIV Infections
            • CAD4TB
            • FujiLAM
            • Zomba, Malawi
              Zomba Central Hospital
            Jan 23, 2023